These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16387162

  • 21. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM, Bravo C, Solé A, Usetti P, Zurbano F, Lama R, De la Torre M, Román A, Pastor A, Laporta R, Cifrián JM, Santos F.
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients.
    Ting LS, Partovi N, Levy RD, Riggs KW, Ensom MH.
    Ann Pharmacother; 2006 Sep; 40(9):1509-16. PubMed ID: 16882870
    [Abstract] [Full Text] [Related]

  • 23. Novel apoptosis assay to analyze immunosuppression.
    Boldt A, Barten MJ, Weiss C, Sagner A, Mohr FW, Gummert JF.
    Cytometry A; 2006 Mar; 69(3):158-60. PubMed ID: 16479615
    [Abstract] [Full Text] [Related]

  • 24. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR, Lin CC, Lian JD.
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [Abstract] [Full Text] [Related]

  • 25. Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine.
    Warnecke G, Avsar M, Steinkamp T, Reinhard R, Niedermeyer J, Simon AR, Haverich A, Strüber M.
    Eur J Cardiothorac Surg; 2005 Sep; 28(3):454-60. PubMed ID: 16054825
    [Abstract] [Full Text] [Related]

  • 26. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A, Szklarek-Kubicka M, Fijałkowska-Morawska J, Nowak D, Rysz J, Mamełka B, Nowicki M.
    Transplant Proc; 2009 Sep; 41(1):188-91. PubMed ID: 19249511
    [Abstract] [Full Text] [Related]

  • 27. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S, Hishida A, Kagawa Y, Kawakami J.
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipients.
    Cattaneo D, Merlini S, Baldelli S, Bartolini B, Nicastri A, Gotti E, Remuzzi G, Perico N.
    Ther Drug Monit; 2006 Oct; 28(5):643-9. PubMed ID: 17038879
    [Abstract] [Full Text] [Related]

  • 29. Pharmacodynamic monitoring of the immunosuppressive therapy in patients after heart transplantation: whole blood flow cytometric analysis of lymphocyte function.
    Barten MJ, Rahmel A, Boldt A, Dhein S, Bittner HB, Tarnok A, Mohr FW, Gummert JF.
    Comput Biol Med; 2007 Oct; 37(10):1367-73. PubMed ID: 17182025
    [Abstract] [Full Text] [Related]

  • 30. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 31. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 32. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 33. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C, Zeier M, Meuer S, Giese T.
    Transplantation; 2010 Jun 15; 89(11):1417-23. PubMed ID: 20463649
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB, Karamperis N, Jørgensen KA.
    Transplant Proc; 2005 May 15; 37(4):1736-8. PubMed ID: 15919449
    [Abstract] [Full Text] [Related]

  • 35. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 15; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 36. Influence of everolimus on cyclosporine Neoral pharmacokinetics in Chinese de novo cardiac transplant recipients.
    Wang CH, Chou NK, Wu FL, Ko WJ, Tsao CI, Chi NH, Hsu RB, Wang SS.
    Transplant Proc; 2006 Sep 15; 38(7):2032-4. PubMed ID: 16979990
    [Abstract] [Full Text] [Related]

  • 37. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP, Canter C, Shepherd R, Lassa-Claxton S, Nadler M.
    Pediatr Transplant; 2007 Aug 15; 11(5):524-9. PubMed ID: 17631021
    [Abstract] [Full Text] [Related]

  • 38. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 39. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
    White M, Ross H, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies R, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J.
    Transplantation; 2006 Sep 27; 82(6):763-70. PubMed ID: 17006323
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A.
    Ther Drug Monit; 2008 Aug 27; 30(4):412-8. PubMed ID: 18641556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.